KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC 50 0.21 nM in Neuro2A cells.
性状
Solid
IC50 & Target[1][2]
IC50: ABHD6 (0.21 nM in Neuro2A cells).
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Hsu KL, et al. Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6). J Med Chem. 2013 Nov 14;56(21):8270-9.